Extended exposure to alkylator chemotherapy: delayed appearance of myelodysplasia View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2009-06

AUTHORS

Marc C. Chamberlain, Jeffrey Raizer

ABSTRACT

OBJECTIVE: A case series of gliomas treated with alkylator-based chemotherapy who subsequently developed myelodysplastic syndrome (tMDS) or acute myelocytic leukemia (AML). BACKGROUND: Alkylator-based chemotherapy is recognized to be leukemogenic; however, it is infrequently described as a delayed consequence of anti-glioma treatment. METHODS: Seven patients (4 men; 3 women) ages 34-69 years (median 44), with gliomas (3 Grade 2; 4 Grade 3) were treated with surgery, all but one with involved-field radiotherapy and all with alkylator-based chemotherapy (temozolomide; 6 patients, nitrosoureas; 5 patients, both agents; 5 patients). RESULTS: Exposure to alkylator-based chemotherapy ranged from 8 to 30 months (median 24). The diagnosis of tMDS was determined by bone marrow biopsy in 7 patients. Seven patients showed chromosomal abnormalities consistent with chemotherapy induced MDS. Three patients were diagnosed with AML as well (in two determined by bone marrow and one at autopsy). Interval from last chemotherapy exposure to diagnosis of tMDS/AML ranged from 3 to 31 months (median 24 months). Two patients were treated with bone marrow transplantation and 5 received supportive care only. Five patients have died, 2 as a consequence of recurrent brain tumor, 1 as a complication of transplantation, and 2 due to AML. CONCLUSIONS: Although rare, induction of tMDS/AML following extended use of alkylator-based chemotherapy may become more relevant with the evolving practice to treat gliomas for protracted periods. Future work to determine at risk patients would be important. More... »

PAGES

229-232

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s11060-008-9764-5

DOI

http://dx.doi.org/10.1007/s11060-008-9764-5

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1030980196

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/19099199


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents, Alkylating", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Brain Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dacarbazine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Follow-Up Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glioma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Myelodysplastic Syndromes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Nitrosourea Compounds", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Reoperation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Analysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survivors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Time Factors", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Fred Hutchinson Cancer Research Center", 
          "id": "https://www.grid.ac/institutes/grid.270240.3", 
          "name": [
            "Department of Neurology and Neurological Surgery, University of Washington, Washington, DC, USA", 
            "Fred Hutchinson Cancer Center, Seattle Cancer Care, Alliance 825 Eastlake Avenue E, Mailstop: G4-940, PO Box 19023, 98109-1023, Seattle, WA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chamberlain", 
        "givenName": "Marc C.", 
        "id": "sg:person.01326261166.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01326261166.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Northwestern University", 
          "id": "https://www.grid.ac/institutes/grid.16753.36", 
          "name": [
            "Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Raizer", 
        "givenName": "Jeffrey", 
        "id": "sg:person.010677556177.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010677556177.51"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1212/wnl.56.1.118", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002499445"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.56.1.118", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002499445"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2004.10.169", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009174773"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11060-004-2028-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017526537", 
          "https://doi.org/10.1007/s11060-004-2028-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1011878214861", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020813811", 
          "https://doi.org/10.1023/a:1011878214861"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1159/000065718", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024124197"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2005.04.3414", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025173270"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0360-3016(90)90096-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027872679"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1215/15228517-2006-003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028514369"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2005.04.6078", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030668601"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm198508293130911", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036712812"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1006175831785", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041043641", 
          "https://doi.org/10.1023/a:1006175831785"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2176/nmc.42.170", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048534183"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2176/nmc.42.170", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048534183"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2176/nmc.42.170", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048534183"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa043330", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052112015"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1023/a:1008382516636", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1056303625"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2003.01.009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064203257"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2003.12.015", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064203991"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/01.wnl.0000127617.89363.84", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064346031"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/01.wnl.0000127617.89363.84", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064346031"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/01.wnl.0000127617.89363.84", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064346031"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/01.wnl.0000127617.89363.84", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064346031"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.57.2.340", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064379939"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.57.2.340", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064379939"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.57.2.340", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064379939"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.57.2.340", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064379939"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1999.17.11.3389", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074545742"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074658183", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2001.19.2.509", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074768339"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2009-06", 
    "datePublishedReg": "2009-06-01", 
    "description": "OBJECTIVE: A case series of gliomas treated with alkylator-based chemotherapy who subsequently developed myelodysplastic syndrome (tMDS) or acute myelocytic leukemia (AML).\nBACKGROUND: Alkylator-based chemotherapy is recognized to be leukemogenic; however, it is infrequently described as a delayed consequence of anti-glioma treatment.\nMETHODS: Seven patients (4 men; 3 women) ages 34-69 years (median 44), with gliomas (3 Grade 2; 4 Grade 3) were treated with surgery, all but one with involved-field radiotherapy and all with alkylator-based chemotherapy (temozolomide; 6 patients, nitrosoureas; 5 patients, both agents; 5 patients).\nRESULTS: Exposure to alkylator-based chemotherapy ranged from 8 to 30 months (median 24). The diagnosis of tMDS was determined by bone marrow biopsy in 7 patients. Seven patients showed chromosomal abnormalities consistent with chemotherapy induced MDS. Three patients were diagnosed with AML as well (in two determined by bone marrow and one at autopsy). Interval from last chemotherapy exposure to diagnosis of tMDS/AML ranged from 3 to 31 months (median 24 months). Two patients were treated with bone marrow transplantation and 5 received supportive care only. Five patients have died, 2 as a consequence of recurrent brain tumor, 1 as a complication of transplantation, and 2 due to AML.\nCONCLUSIONS: Although rare, induction of tMDS/AML following extended use of alkylator-based chemotherapy may become more relevant with the evolving practice to treat gliomas for protracted periods. Future work to determine at risk patients would be important.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s11060-008-9764-5", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1094205", 
        "issn": [
          "0167-594X", 
          "1573-7373"
        ], 
        "name": "Journal of Neuro-Oncology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "93"
      }
    ], 
    "name": "Extended exposure to alkylator chemotherapy: delayed appearance of myelodysplasia", 
    "pagination": "229-232", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "93968c134ed2da3e01365b606378cfc4f3607e5c7efdfa8de8c21609b1839885"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "19099199"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8309335"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s11060-008-9764-5"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1030980196"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s11060-008-9764-5", 
      "https://app.dimensions.ai/details/publication/pub.1030980196"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T15:05", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8663_00000532.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs11060-008-9764-5"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11060-008-9764-5'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11060-008-9764-5'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11060-008-9764-5'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11060-008-9764-5'


 

This table displays all metadata directly associated to this object as RDF triples.

213 TRIPLES      21 PREDICATES      67 URIs      38 LITERALS      26 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s11060-008-9764-5 schema:about N09626de743c043108dc9c0288ecfb853
2 N204d58b029c84717bc6be36e5dd40422
3 N2ad8b87c04684264a1a72637bb8582af
4 N4abaef0e811e407c8762254ff1e22e94
5 N5070bdaa81ef4bee906a852c971123ff
6 N6cb868b405da4faab0de32f30bf96da3
7 N8b55374461f649308ad8d099c6d97523
8 N97991289ec4b40a7b854ba5efc18eef9
9 Na525954eb5f84afc86c5b7221e3c353a
10 Na54d1ced135a40e19f70e503e7958f89
11 Na83b15e50e6c4d70807455f1934c7d3f
12 Nb467d95c871744e0bbdcac03564dd1ce
13 Nda7dd37bcade4d5583ac2e4e27f6c183
14 Nec5cc20e786a49d9a9137eb9446396c8
15 Nf47c7e305aba4366926d1a493fffeded
16 Nf8c7fcd84257425ba5f0b3fa78f79b39
17 Nfb385ddac6ee4242baa7eff94b41d69e
18 anzsrc-for:11
19 anzsrc-for:1112
20 schema:author N84418dd5b6b14e94807b7d36e92c2753
21 schema:citation sg:pub.10.1007/s11060-004-2028-0
22 sg:pub.10.1023/a:1006175831785
23 sg:pub.10.1023/a:1011878214861
24 https://app.dimensions.ai/details/publication/pub.1074658183
25 https://doi.org/10.1016/0360-3016(90)90096-3
26 https://doi.org/10.1023/a:1008382516636
27 https://doi.org/10.1056/nejm198508293130911
28 https://doi.org/10.1056/nejmoa043330
29 https://doi.org/10.1159/000065718
30 https://doi.org/10.1200/jco.1999.17.11.3389
31 https://doi.org/10.1200/jco.2001.19.2.509
32 https://doi.org/10.1200/jco.2003.01.009
33 https://doi.org/10.1200/jco.2003.12.015
34 https://doi.org/10.1200/jco.2004.10.169
35 https://doi.org/10.1200/jco.2005.04.3414
36 https://doi.org/10.1200/jco.2005.04.6078
37 https://doi.org/10.1212/01.wnl.0000127617.89363.84
38 https://doi.org/10.1212/wnl.56.1.118
39 https://doi.org/10.1212/wnl.57.2.340
40 https://doi.org/10.1215/15228517-2006-003
41 https://doi.org/10.2176/nmc.42.170
42 schema:datePublished 2009-06
43 schema:datePublishedReg 2009-06-01
44 schema:description OBJECTIVE: A case series of gliomas treated with alkylator-based chemotherapy who subsequently developed myelodysplastic syndrome (tMDS) or acute myelocytic leukemia (AML). BACKGROUND: Alkylator-based chemotherapy is recognized to be leukemogenic; however, it is infrequently described as a delayed consequence of anti-glioma treatment. METHODS: Seven patients (4 men; 3 women) ages 34-69 years (median 44), with gliomas (3 Grade 2; 4 Grade 3) were treated with surgery, all but one with involved-field radiotherapy and all with alkylator-based chemotherapy (temozolomide; 6 patients, nitrosoureas; 5 patients, both agents; 5 patients). RESULTS: Exposure to alkylator-based chemotherapy ranged from 8 to 30 months (median 24). The diagnosis of tMDS was determined by bone marrow biopsy in 7 patients. Seven patients showed chromosomal abnormalities consistent with chemotherapy induced MDS. Three patients were diagnosed with AML as well (in two determined by bone marrow and one at autopsy). Interval from last chemotherapy exposure to diagnosis of tMDS/AML ranged from 3 to 31 months (median 24 months). Two patients were treated with bone marrow transplantation and 5 received supportive care only. Five patients have died, 2 as a consequence of recurrent brain tumor, 1 as a complication of transplantation, and 2 due to AML. CONCLUSIONS: Although rare, induction of tMDS/AML following extended use of alkylator-based chemotherapy may become more relevant with the evolving practice to treat gliomas for protracted periods. Future work to determine at risk patients would be important.
45 schema:genre research_article
46 schema:inLanguage en
47 schema:isAccessibleForFree false
48 schema:isPartOf N286ae37b0dfa41f38138fcd32b7db1cf
49 Nc6a07800b6d0434eb6da777dedaa4936
50 sg:journal.1094205
51 schema:name Extended exposure to alkylator chemotherapy: delayed appearance of myelodysplasia
52 schema:pagination 229-232
53 schema:productId N370235e327664dc0952ec6dde2a4d36a
54 N4e11c72f725a483589a6087e0d52a80b
55 N91498b2c255b46c5891cb2f874e336b7
56 Nd308ec7c4e6f4f09a98539da690f0995
57 Nff2e6016d7064a42a010fbb3451433ef
58 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030980196
59 https://doi.org/10.1007/s11060-008-9764-5
60 schema:sdDatePublished 2019-04-10T15:05
61 schema:sdLicense https://scigraph.springernature.com/explorer/license/
62 schema:sdPublisher Ncdbb993156b345e3aafee7aa33be2299
63 schema:url http://link.springer.com/10.1007%2Fs11060-008-9764-5
64 sgo:license sg:explorer/license/
65 sgo:sdDataset articles
66 rdf:type schema:ScholarlyArticle
67 N09626de743c043108dc9c0288ecfb853 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
68 schema:name Aged
69 rdf:type schema:DefinedTerm
70 N204d58b029c84717bc6be36e5dd40422 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
71 schema:name Follow-Up Studies
72 rdf:type schema:DefinedTerm
73 N2740b90f66ce48e2904f1810989e5e22 rdf:first sg:person.010677556177.51
74 rdf:rest rdf:nil
75 N286ae37b0dfa41f38138fcd32b7db1cf schema:volumeNumber 93
76 rdf:type schema:PublicationVolume
77 N2ad8b87c04684264a1a72637bb8582af schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
78 schema:name Antineoplastic Agents, Alkylating
79 rdf:type schema:DefinedTerm
80 N370235e327664dc0952ec6dde2a4d36a schema:name readcube_id
81 schema:value 93968c134ed2da3e01365b606378cfc4f3607e5c7efdfa8de8c21609b1839885
82 rdf:type schema:PropertyValue
83 N4abaef0e811e407c8762254ff1e22e94 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
84 schema:name Myelodysplastic Syndromes
85 rdf:type schema:DefinedTerm
86 N4e11c72f725a483589a6087e0d52a80b schema:name pubmed_id
87 schema:value 19099199
88 rdf:type schema:PropertyValue
89 N5070bdaa81ef4bee906a852c971123ff schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
90 schema:name Male
91 rdf:type schema:DefinedTerm
92 N6cb868b405da4faab0de32f30bf96da3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
93 schema:name Brain Neoplasms
94 rdf:type schema:DefinedTerm
95 N84418dd5b6b14e94807b7d36e92c2753 rdf:first sg:person.01326261166.36
96 rdf:rest N2740b90f66ce48e2904f1810989e5e22
97 N8b55374461f649308ad8d099c6d97523 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Adult
99 rdf:type schema:DefinedTerm
100 N91498b2c255b46c5891cb2f874e336b7 schema:name doi
101 schema:value 10.1007/s11060-008-9764-5
102 rdf:type schema:PropertyValue
103 N97991289ec4b40a7b854ba5efc18eef9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Humans
105 rdf:type schema:DefinedTerm
106 Na525954eb5f84afc86c5b7221e3c353a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Middle Aged
108 rdf:type schema:DefinedTerm
109 Na54d1ced135a40e19f70e503e7958f89 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Time Factors
111 rdf:type schema:DefinedTerm
112 Na83b15e50e6c4d70807455f1934c7d3f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Survival Analysis
114 rdf:type schema:DefinedTerm
115 Nb467d95c871744e0bbdcac03564dd1ce schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Glioma
117 rdf:type schema:DefinedTerm
118 Nc6a07800b6d0434eb6da777dedaa4936 schema:issueNumber 2
119 rdf:type schema:PublicationIssue
120 Ncdbb993156b345e3aafee7aa33be2299 schema:name Springer Nature - SN SciGraph project
121 rdf:type schema:Organization
122 Nd308ec7c4e6f4f09a98539da690f0995 schema:name nlm_unique_id
123 schema:value 8309335
124 rdf:type schema:PropertyValue
125 Nda7dd37bcade4d5583ac2e4e27f6c183 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Reoperation
127 rdf:type schema:DefinedTerm
128 Nec5cc20e786a49d9a9137eb9446396c8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Female
130 rdf:type schema:DefinedTerm
131 Nf47c7e305aba4366926d1a493fffeded schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Nitrosourea Compounds
133 rdf:type schema:DefinedTerm
134 Nf8c7fcd84257425ba5f0b3fa78f79b39 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Survivors
136 rdf:type schema:DefinedTerm
137 Nfb385ddac6ee4242baa7eff94b41d69e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Dacarbazine
139 rdf:type schema:DefinedTerm
140 Nff2e6016d7064a42a010fbb3451433ef schema:name dimensions_id
141 schema:value pub.1030980196
142 rdf:type schema:PropertyValue
143 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
144 schema:name Medical and Health Sciences
145 rdf:type schema:DefinedTerm
146 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
147 schema:name Oncology and Carcinogenesis
148 rdf:type schema:DefinedTerm
149 sg:journal.1094205 schema:issn 0167-594X
150 1573-7373
151 schema:name Journal of Neuro-Oncology
152 rdf:type schema:Periodical
153 sg:person.010677556177.51 schema:affiliation https://www.grid.ac/institutes/grid.16753.36
154 schema:familyName Raizer
155 schema:givenName Jeffrey
156 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010677556177.51
157 rdf:type schema:Person
158 sg:person.01326261166.36 schema:affiliation https://www.grid.ac/institutes/grid.270240.3
159 schema:familyName Chamberlain
160 schema:givenName Marc C.
161 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01326261166.36
162 rdf:type schema:Person
163 sg:pub.10.1007/s11060-004-2028-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017526537
164 https://doi.org/10.1007/s11060-004-2028-0
165 rdf:type schema:CreativeWork
166 sg:pub.10.1023/a:1006175831785 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041043641
167 https://doi.org/10.1023/a:1006175831785
168 rdf:type schema:CreativeWork
169 sg:pub.10.1023/a:1011878214861 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020813811
170 https://doi.org/10.1023/a:1011878214861
171 rdf:type schema:CreativeWork
172 https://app.dimensions.ai/details/publication/pub.1074658183 schema:CreativeWork
173 https://doi.org/10.1016/0360-3016(90)90096-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027872679
174 rdf:type schema:CreativeWork
175 https://doi.org/10.1023/a:1008382516636 schema:sameAs https://app.dimensions.ai/details/publication/pub.1056303625
176 rdf:type schema:CreativeWork
177 https://doi.org/10.1056/nejm198508293130911 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036712812
178 rdf:type schema:CreativeWork
179 https://doi.org/10.1056/nejmoa043330 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052112015
180 rdf:type schema:CreativeWork
181 https://doi.org/10.1159/000065718 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024124197
182 rdf:type schema:CreativeWork
183 https://doi.org/10.1200/jco.1999.17.11.3389 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074545742
184 rdf:type schema:CreativeWork
185 https://doi.org/10.1200/jco.2001.19.2.509 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074768339
186 rdf:type schema:CreativeWork
187 https://doi.org/10.1200/jco.2003.01.009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064203257
188 rdf:type schema:CreativeWork
189 https://doi.org/10.1200/jco.2003.12.015 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064203991
190 rdf:type schema:CreativeWork
191 https://doi.org/10.1200/jco.2004.10.169 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009174773
192 rdf:type schema:CreativeWork
193 https://doi.org/10.1200/jco.2005.04.3414 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025173270
194 rdf:type schema:CreativeWork
195 https://doi.org/10.1200/jco.2005.04.6078 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030668601
196 rdf:type schema:CreativeWork
197 https://doi.org/10.1212/01.wnl.0000127617.89363.84 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064346031
198 rdf:type schema:CreativeWork
199 https://doi.org/10.1212/wnl.56.1.118 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002499445
200 rdf:type schema:CreativeWork
201 https://doi.org/10.1212/wnl.57.2.340 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064379939
202 rdf:type schema:CreativeWork
203 https://doi.org/10.1215/15228517-2006-003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028514369
204 rdf:type schema:CreativeWork
205 https://doi.org/10.2176/nmc.42.170 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048534183
206 rdf:type schema:CreativeWork
207 https://www.grid.ac/institutes/grid.16753.36 schema:alternateName Northwestern University
208 schema:name Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
209 rdf:type schema:Organization
210 https://www.grid.ac/institutes/grid.270240.3 schema:alternateName Fred Hutchinson Cancer Research Center
211 schema:name Department of Neurology and Neurological Surgery, University of Washington, Washington, DC, USA
212 Fred Hutchinson Cancer Center, Seattle Cancer Care, Alliance 825 Eastlake Avenue E, Mailstop: G4-940, PO Box 19023, 98109-1023, Seattle, WA, USA
213 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...